What we're reading, March 29, 2016: the Obama administration is expected to announce new measures to combat opioid addiction; cholesterol test results from Theranos could throw off doctors' decisions; and Republicans aren't talking as much about Obamacare on the campaign trail.
With the opioid epidemic receiving more and more attention in the US, the Obama administration plans to unveil measures to help combat the issue. The president plans to increase access to a medication that combats drug addiction by allowing qualified physicians to prescribe the drug to twice as many patients as they are currently allowed, according to STAT. In addition, Obama is reportedly creating a task force to advance access to mental health and substance use disorder treatment.
Doctors might want to get a second opinion if they base medical decisions on cholesterol tests done by Theranos Inc. According to The Wall Street Journal, Theranos’ results for total cholesterol were lower by 9.3% on average compared with the 2 largest laboratory companies in the US. Researchers from Mount Sinai discovered the discrepancy and published their results in the Journal of Clinical Investigation. They wrote that the average gap could lead doctors to “either inappropriately initiate or fail to appropriately initiate statin therapy.”
Republicans may not like President Obama’s Affordable Care Act, but they aren’t talking much about it any more. This election year, Republican candidates are not allowing talk of replacing Obamacare to dominate the dialogue, and neither party is viewing healthcare reform as a top issue, reported The New York Times. The reason is simple: despite its controversy, the law has taken hold with some impressive numbers. Republicans have even admitted that they would keep certain popular provisions.
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Integrated CKD Care Model Cuts ED Visits by 30%, Boosts Specialized Treatment
April 21st 2025An analysis of an interdisciplinary care model for managing chronic kidney disease (CKD) shows hospital admissions dropped by 26% and emergency department (ED) visits decreased by 30% after clinic initiation.
Read More